Join NBTS’s campaign to raise awareness about the importance of biomarker testing and clinical trials for patients with brain tumors.
READ MOREPublished on March 11, 2025 in government update, Advocacy
The following is a brief, high-level update on the complicated and very fluid political situation unfolding around a possible government shutdown – and implications for federal funding of brain tumor research.
Unless Congress acts, government funding will run out on Friday (March 14). The President recently called for Congress to pass a “Continuing Resolution (CR),” which would fund the government through the end of Fiscal Year 2025 (September 30) in order to avert a federal shutdown.
Over the past weekend, Congress released the text of the proposed CR, which includes a more than 50% cut to funding for the Department of Defense’s (DoD) Congressionally Directed Medical Research Program (CDMRP), which funds critical glioblastoma and other adult and pediatric brain tumor research through its Peer-Reviewed Cancer Research Program (PRCRP).
NBTS has has been working diligently – on our own and with umbrella advocacy groups of which we are a part – to directly encourage our supporters in Congress to urge their colleagues to come together and finish a Fiscal Year 2025 appropriations package that would sufficiently fund cancer research through the PRCRP, as well as the National Institutes for Health (NIH), instead of simply passing a CR. We also issued an advocate action alert in January asking you to reach out to Congress to support the PRCRP and the NIH’s National Cancer Institute. Additionally, we issued a second action alert specific to NIH funding in late February.
If you haven’t already, please consider completing both of these action alerts to remind Congress of the importance of brain tumor research both at the DoD and the NIH. We continue to hear from congressional offices that they want to hear from their constituents about the priority of funding cancer research including for pediatric and adult brain tumors.
We will continue to keep you updated as developments unfold. In the meantime, we will continue to ensure that the voices of the brain tumor community are being heard on Capitol Hill.
TAGGED WITH: advocacy, Brain tumor news, brain tumor advocacy